Dhansa Labs is an Indian agrochemical manufacturer that has spent four decades turning a single molecule - the herbicide 2,4-D - into a defensible industrial position, and is now using the cash and chemistry logic of that core to reach into renewable energy. The company was founded in 1985, is run by the third generation of the founding family, and listed on the NSE Emerge platform in July 2024 under its former name, Ambey Laboratories, before rebranding to Dhansa Labs in early 2026. The recurring approach is visible across every part of the business: own the raw-material step, control the manufacturing site tightly, and sell to a concentrated domestic customer base - a formula it is now transplanting from crop-protection chemicals into compressed biogas and biomass pellets. # Business segments Three engines at different stages - a mature agrochemical cash generator, a small branded hygiene line sold through the same channels, and a green-energy platform under construction that applies the same backward-integration logic to Napier grass and biomass. ## 1. Agrochemicals: the 2,4-D anchor that funds everything else **The company is India’s third-largest maker of 2,4-D, a broadleaf herbicide, and runs a single backward-integrated plant that supplies over 250 domestic customers - this is where nearly all the revenue comes from.** - **Backward integration to the base chemical** - the Behror, Rajasthan plant makes its own starting materials for most product lines, which management says gives it tighter quality control and lower costs than competitors who buy intermediates on the open market. - **One site, many molecules** - the single 5-acre facility houses capacity for 5,000 metric tonnes of 2,4-D annually, plus lines for Pretilachlor, Metribuzin and other agrochemicals, and is Zero Liquid Discharge compliant with its own 125,000-litre-per-day effluent treatment plant. - **A domestic book concentrated in three states** - over 94% of sales stay within India, with Delhi, Haryana and Rajasthan together accounting for roughly 90% of domestic revenue, so the business rises and falls with the north-Indian monsoon and the cropping decisions of farmers in that belt. - **Atrazine is the next leg** - a new line for Atrazine, another herbicide, is being built at an investment of about ₹30 crores and is expected to start production by August 2026, with the company targeting roughly ₹120-140 crores of additional annual revenue once it stabilises. - **The moat is registrations and relationships** - the company holds more than 200 product and combination registrations, and counts Dhanuka Agritech and Safex Chemicals among its larger customers, which creates switching friction in a regulated industry where re-registering a supplier is slow. ## 2. Home hygiene: a branded sideline sold through the same pipes **A small portfolio of cleaning and disinfectant products under the “Ambetol” brand that piggybacks on the agrochemical distribution network - it contributed just over 3% of revenue in FY26.** - **Same factory, same channels** - the home hygiene range, from phenyl and floor cleaners to hand wash and moth repellent balls, is manufactured at the Behror plant and sold to the same domestic customer base that buys crop-protection chemicals. - **A brand, not a commodity** - unlike the bulk agrochemical business, these products carry the company’s own “Ambetol” label and reach residential, commercial and institutional buyers, giving the company a small direct-to-consumer presence without building a separate sales force. ## 3. Renewable energy: the backward-integration playbook applied to grass and pellets **Two wholly owned subsidiaries are building a compressed-biogas plant fed by captive Napier grass farms and a biomass-pellet operation - both are pre-revenue and designed to sell fuel and carbon credits into a policy-supported market.** - **Gas from grass, not waste** - the 15-tonne-per-day compressed-biogas project in Bundi, Rajasthan is anchored by over 350 acres of leased land growing Napier grass, a feedstock chosen because its cost stays predictable for 10-20 years, unlike agro-waste that fluctuates with harvests and competing buyers. - **Carbon credits are a second revenue stream** - the Napier grass cultivation itself is expected to generate carbon credits, so the project earns twice from the same acreage: once from selling biogas and again from selling offsets. - **Pellets as a coal substitute** - the second subsidiary, Dhansa Biofuels Power, is developing a biomass-pellet business aimed at factories that need to replace coal in their boilers, tapping the same policy push for industrial decarbonisation. # Group structure and partners **The listed parent owns two young renewable-energy subsidiaries, and the promoter family holds nearly 70% of the equity after a gift-driven consolidation in late 2025.** - The parent, Dhansa Labs Ltd, operates from a registered office in South West Delhi and a corporate office in Gurugram, and had no subsidiaries at all until the green-energy vehicle was incorporated in 2025. - Dhansa Green Energy Private Limited houses the 15-TPD compressed-biogas project and the Napier grass cultivation; Dhansa Biofuels Power Private Limited holds the biomass-pellet business - both are wholly owned. - Promoters Archit Gupta (CEO) and Arpit Gupta (Director Operations) were part of an off-market inter-se transfer of 1,74,37,420 shares in December 2025, with Archit Gupta receiving 87,18,710 shares, and the aggregate promoter and promoter group holding remaining unchanged. - A related entity, Aromatic Rasayan Private Limited, shares directors and shareholders with Dhansa Labs and is a regular counterparty for raw-material and finished-goods transactions, with an approved annual value of up to ₹250 crores for the coming years.